FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198675803> ?p ?o ?g. }

• W3198675803 abstract "Background: The differential diagnosis of estrogen receptor-positive (ER+) pathway-activated systems by using a labeled antiestrogen helps to select the patients for optimal response to endocrine therapy and to discontinue the treatment when resistance occurs. The authors' purpose was to synthesize chelator-tamoxifen conjugates for imaging ER (+) diseases. Materials and Methods: A hydroxypropyl linker was incorporated between either cyclam or cyclam diacetic acid and tamoxifen analog to produce SC-05-L-1 (Z-1-(1,4,8,11-tetraazacyclotetradecan-1-yl)-3-((5-(4-(2-(diethylamino)ethoxy)phenyl)-4,5-diphenylpent-4-en-1-yl)oxy)propan-2-ol) and SC-05-N-1 (Z-2,2'-(4-(3-((5-(4-(2-(diethylamino)ethoxy)phenyl)-4,5-diphenylpent-4-en-1-yl)oxy)-2-hydroxy-propyl)-1,4,8,11-tetraazacyclotetradecane-1,8-diyl)diacetic acid), respectively. In vitro cell uptake and cell/media ratios of 99mTc-SC-05-L-1 and 99mTc- SC-05-N-1 in ER (+) ovarian cancer cells (TOV-112D and OVCAR3) were performed. To ascertain the specificity of cell uptake, the cell uptake was blocked with estrone. In vivo99mTc-SC-05-L-1 or 99mTc-SC-05-N-1 single-photon emission computed tomography/computed tomography was conducted in tumor-bearing rodents and compared to 18F-fluoro-2-deoxy-d-glucose (18F-FDG) positron emission tomography/magnetic resonance imaging (a reference technology). Results: The radiochemical purities of 99mTc-SC-05-L-1 and 99mTc-SC-05-N-1 were greater than 99% (n = 10). 99mTc-SC-05-L-1 had higher cell/media ratios than 99mTc-SC-05-N-1 in OVCAR-3 ER (+) cells. The cell uptake of 99mTc-SC-05-L-1 was blocked 80% by estrone indicating an ER-mediated process occurred. 99mTc-SC-05-N-1 was further selected for in vivo imaging studies due to higher maximum tolerated dose and superior water solubility than 99mTc-SC-05-L-1. 99mTc-SC-05-N-1 showed higher tumor uptake and tumor/muscle count density ratios than 18F-FDG in tumor-bearing rodents. Conclusion:99mTc-SC-05-N-1 showed better differential diagnosis of ovarian tumors than 18F-FDG, indicating great promising in chelator-tamoxifen conjugate for ER pathway-directed systems imaging." @default.
• W3198675803 created "2021-09-13" @default.
• W3198675803 creator A5004651213 @default.
• W3198675803 creator A5013867965 @default.
• W3198675803 creator A5014468169 @default.
• W3198675803 creator A5014503439 @default.
• W3198675803 creator A5041976538 @default.
• W3198675803 creator A5053093867 @default.
• W3198675803 creator A5070245711 @default.
• W3198675803 creator A5072616610 @default.
• W3198675803 creator A5090168860 @default.
• W3198675803 date "2021-09-02" @default.
• W3198675803 modified "2023-09-23" @default.
• W3198675803 title "Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors" @default.
• W3198675803 cites W1871085519 @default.
• W3198675803 cites W1966469782 @default.
• W3198675803 cites W1982144119 @default.
• W3198675803 cites W1987957186 @default.
• W3198675803 cites W2017596184 @default.
• W3198675803 cites W2020479728 @default.
• W3198675803 cites W2032599066 @default.
• W3198675803 cites W2037808314 @default.
• W3198675803 cites W2040655140 @default.
• W3198675803 cites W2042170307 @default.
• W3198675803 cites W2047863929 @default.
• W3198675803 cites W2048969555 @default.
• W3198675803 cites W2062561340 @default.
• W3198675803 cites W2063307620 @default.
• W3198675803 cites W2068029597 @default.
• W3198675803 cites W2078919991 @default.
• W3198675803 cites W2082362356 @default.
• W3198675803 cites W2083255123 @default.
• W3198675803 cites W2127603929 @default.
• W3198675803 cites W2143474295 @default.
• W3198675803 cites W2147746851 @default.
• W3198675803 cites W2326664063 @default.
• W3198675803 cites W2331068585 @default.
• W3198675803 cites W2401948043 @default.
• W3198675803 cites W2535844677 @default.
• W3198675803 cites W2560720902 @default.
• W3198675803 cites W2563556250 @default.
• W3198675803 cites W2752905556 @default.
• W3198675803 cites W2884709581 @default.
• W3198675803 cites W2894176149 @default.
• W3198675803 cites W2981691849 @default.
• W3198675803 doi "https://doi.org/10.1089/cbr.2021.0169" @default.
• W3198675803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34491835" @default.
• W3198675803 hasPublicationYear "2021" @default.
• W3198675803 type Work @default.
• W3198675803 sameAs 3198675803 @default.
• W3198675803 citedByCount "1" @default.
• W3198675803 countsByYear W31986758032021 @default.
• W3198675803 crossrefType "journal-article" @default.
• W3198675803 hasAuthorship W3198675803A5004651213 @default.
• W3198675803 hasAuthorship W3198675803A5013867965 @default.
• W3198675803 hasAuthorship W3198675803A5014468169 @default.
• W3198675803 hasAuthorship W3198675803A5014503439 @default.
• W3198675803 hasAuthorship W3198675803A5041976538 @default.
• W3198675803 hasAuthorship W3198675803A5053093867 @default.
• W3198675803 hasAuthorship W3198675803A5070245711 @default.
• W3198675803 hasAuthorship W3198675803A5072616610 @default.
• W3198675803 hasAuthorship W3198675803A5090168860 @default.
• W3198675803 hasConcept C121608353 @default.
• W3198675803 hasConcept C126322002 @default.
• W3198675803 hasConcept C134306372 @default.
• W3198675803 hasConcept C178790620 @default.
• W3198675803 hasConcept C185592680 @default.
• W3198675803 hasConcept C197336794 @default.
• W3198675803 hasConcept C197404232 @default.
• W3198675803 hasConcept C202751555 @default.
• W3198675803 hasConcept C2775842073 @default.
• W3198675803 hasConcept C2776067312 @default.
• W3198675803 hasConcept C2776384444 @default.
• W3198675803 hasConcept C2777176818 @default.
• W3198675803 hasConcept C2777944059 @default.
• W3198675803 hasConcept C2989005 @default.
• W3198675803 hasConcept C33923547 @default.
• W3198675803 hasConcept C530470458 @default.
• W3198675803 hasConcept C544153396 @default.
• W3198675803 hasConcept C55493867 @default.
• W3198675803 hasConcept C71924100 @default.
• W3198675803 hasConcept C84606932 @default.
• W3198675803 hasConceptScore W3198675803C121608353 @default.
• W3198675803 hasConceptScore W3198675803C126322002 @default.
• W3198675803 hasConceptScore W3198675803C134306372 @default.
• W3198675803 hasConceptScore W3198675803C178790620 @default.
• W3198675803 hasConceptScore W3198675803C185592680 @default.
• W3198675803 hasConceptScore W3198675803C197336794 @default.
• W3198675803 hasConceptScore W3198675803C197404232 @default.
• W3198675803 hasConceptScore W3198675803C202751555 @default.
• W3198675803 hasConceptScore W3198675803C2775842073 @default.
• W3198675803 hasConceptScore W3198675803C2776067312 @default.
• W3198675803 hasConceptScore W3198675803C2776384444 @default.
• W3198675803 hasConceptScore W3198675803C2777176818 @default.
• W3198675803 hasConceptScore W3198675803C2777944059 @default.
• W3198675803 hasConceptScore W3198675803C2989005 @default.
• W3198675803 hasConceptScore W3198675803C33923547 @default.
• W3198675803 hasConceptScore W3198675803C530470458 @default.
• W3198675803 hasConceptScore W3198675803C544153396 @default.
• W3198675803 hasConceptScore W3198675803C55493867 @default.

• next